Regenerative medicine for cost and time efficient pet treatment
There are a number of different veterinary diseases for which current medicine (surgical techniques and drugs) offer absolutely no solution like osteoarthritis and neurological, autoimmune and inflammatory diseases. Today, the tre...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
AGL2008-02428
TERAPIA CELULAR EN VETERINARIA: CARACTERIZACION DE CELULAS T...
115K€
Cerrado
PTQ-09-02-01799
BIOPRODUCTOS INNOVADORES Y COMPETITIVOS PARA SU APLICACION E...
56K€
Cerrado
AGL2017-84411-P
OPTIMIZACION DEL USO DE MSCS EN PATOLOGIAS ARTICULARES EN CA...
121K€
Cerrado
OPTISTEM
Optimization of stem cell therapy for clinical trials of deg...
17M€
Cerrado
PTQ-09-02-01275
BIOPRODUCTOS INNOVADORES Y COMPETITIVOS PARA SU APLICACIÓN E...
60K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
There are a number of different veterinary diseases for which current medicine (surgical techniques and drugs) offer absolutely no solution like osteoarthritis and neurological, autoimmune and inflammatory diseases. Today, the treatment of these disorders could get benefit from the administration of stem cells. At Vetherapy we provide stem cell therapies and regenerative products for veterinary application, in an easy, ready-to-use, and affordable manner. We have used our knowledge and experience to develop a whole set of products that use stem cells and stem cell’s derivatives to a variety of scenarios, from injury to degenerative disorders. The secret of our success is based on an innovative technology that allowed us to overcome one of the major difficulties of the application of stem cells: cell viability. Our technology extends cell viability up to 48h (vs. 4-6h of current methods) and enables the delivery of a ready-to-use high quality product, anywhere within this time frame.
Following very promising pre-clinical results where we tested the safety and efficacy of our product, we now plan to commercialize our inventions PET-STEM and WOUND FIX® by optimizing their design and carrying out a large veterinary clinical trial.
The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast sound wider deployment of PET-STEM and WOUND FIX® and their market uptake.